A mutation, valine to glutamine in the TM region of the HER2 receptor causes dimerization of the receptor, even in the absence of the ligand, transforming it into the oncoprotein NEU, a constitutively active protein tyrosine kinase.
#Unit 4. Cell Communication and Cell Signaling#Cancer#Part B Pointers